semaglutide medicare to Cover Weight-Loss Drug Wegovy for Certain Patients Are you eligible? Medicare's new

Any product marketed as retatrutide outside of a regulated clinical trial has not been approved for safety or efficacy and may pose significant health risks

Retatrutide: This is a fascinating compound for the research community

How Dose Escalation and Medication Switching Address Plateaus One evidence-based strategy for breaking through a plateau is dose optimization

[1] [2] Administered as a once-weekly subcutaneous injection, Ozempic has demonstrated significant efficacy in improving glycaemic control in clinical trials

Using advanced PET imaging, his team shows how impaired glucose use in the brain contrasts with preserved ketone uptakeopening the door for ketogenic strategies, MCTs, and carb reduction as therapies